Literature DB >> 6435952

Site visits in a multicenter ophthalmic clinical trial.

G H Cassel, F L Ferris.   

Abstract

Site visits were conducted to 19 clinical centers in a large multicenter ophthalmologic clinical trial, the Early Treatment Diabetic Retinopathy Study (ETDRS). The purpose of these site visits was to ensure the consistency of study procedures among clinics and to verify that these procedures were being carried out in accordance with the ETDRS Manual of Operations. The five major aspects of this quality control program are as follows: To monitor and review each clinical center's organization and procedures; To promote comparability of participating centers in all important aspects of the clinical trial; To gain more understanding about special problems facing individual clinical centers; To establish good rapport between the site visitor and clinic staff to aid future clinic monitoring; To promote and maintain enthusiasm for the study. The ETDRS clinical center site visits were conducted by using an observational approach. Presite visit preparations included the formation of a site visit agenda and the design of a site visit form, providing a guide for the site visitor, and a list of the topics that were to be reviewed at each center. Important concerns common to all site visits proved beneficial in the ETDRS.

Entities:  

Mesh:

Year:  1984        PMID: 6435952     DOI: 10.1016/0197-2456(84)90029-1

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  2 in total

1.  Successful coordination and execution of nontherapeutic studies in a cooperative group setting: lessons learned from Children's Oncology Group studies.

Authors:  Andrea Carter; Wendy Landier; Amy Schad; Allison Moser; Alexandra Schaible; Cara Hanby; Seira Kurian; F Lennie Wong; Doojduen Villaluna; Smita Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

2.  Quality control and data-handling in multicentre studies: the case of the Multicentre Project for Tuberculosis Research.

Authors:  T Caloto
Journal:  BMC Med Res Methodol       Date:  2001-12-21       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.